NP Life Sciences Health Industry Group Inc.
ACAT · OTCMCIK 1781726fmd_1EV0Y27TSHA0X8AYB286XRRGM7Services · Services-Educational ServicesTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2023, 20 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q4 FY2023
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +122.2%
NP Life Sciences Health Industry Group Inc. (ACAT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $164,621 | $102,002 | +61.4% | 10-K 2024-04-16 · proof |
| Operating income | -$690 | -$18,855 | 10-K 2024-04-16 · proof | |
| Net income | -$2,935 | -$18,856 | 10-K 2024-04-16 · proof | |
| Cash from operating activities | -$73,607 | $93,873 | -178.4% | 10-K 2024-04-16 · proof |
| Total assets | $76,864 | $127,784 | -39.8% | 10-K 2024-04-16 · proof |
| Total liabilities | $60,483 | $108,468 | -44.2% | 10-K 2024-04-16 · proof |
| Cash and cash equivalents | $70,614 | $121,859 | -42.1% | 10-K 2024-04-16 · proof |
- What was NP Life Sciences Health Industry Group Inc. (ACAT)'s revenue in fiscal 2023?
- NP Life Sciences Health Industry Group Inc. (ACAT) reported revenue of $164,621 for fiscal 2023 (the year ended Dec 31, 2023), against $102,002 the year before (+61.4%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was NP Life Sciences Health Industry Group Inc. (ACAT)'s operating income in fiscal 2023?
- NP Life Sciences Health Industry Group Inc. (ACAT) reported operating income of -$690 for fiscal 2023 (the year ended Dec 31, 2023), against -$18,855 the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was NP Life Sciences Health Industry Group Inc. (ACAT)'s net income in fiscal 2023?
- NP Life Sciences Health Industry Group Inc. (ACAT) reported net income of -$2,935 for fiscal 2023 (the year ended Dec 31, 2023), against -$18,856 the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was NP Life Sciences Health Industry Group Inc. (ACAT)'s cash from operating activities in fiscal 2023?
- NP Life Sciences Health Industry Group Inc. (ACAT) reported cash from operating activities of -$73,607 for fiscal 2023 (the year ended Dec 31, 2023), against $93,873 the year before (-178.4%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What are NP Life Sciences Health Industry Group Inc. (ACAT)'s total assets?
- As of Dec 31, 2023, NP Life Sciences Health Industry Group Inc. (ACAT) reported total assets of $76,864, against $127,784 a year earlier (-39.8%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What are NP Life Sciences Health Industry Group Inc. (ACAT)'s total liabilities?
- As of Dec 31, 2023, NP Life Sciences Health Industry Group Inc. (ACAT) reported total liabilities of $60,483, against $108,468 a year earlier (-44.2%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What are NP Life Sciences Health Industry Group Inc. (ACAT)'s cash and cash equivalents?
- As of Dec 31, 2023, NP Life Sciences Health Industry Group Inc. (ACAT) reported cash and cash equivalents of $70,614, against $121,859 a year earlier (-42.1%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ACAT&period_type=annual&limit=5"Information only, not investment advice.